MMN: from immunological cross-talk to conduction block.

Area of Science:

• Neurology
• Immunology
• Neuroinflammation

Background:

• Multifocal motor neuropathy (MMN) is a rare inflammatory demyelinating neuropathy.
• It presents with progressive, asymmetric distal limb weakness and conduction block (CB).
• MMN can clinically mimic motor neuron disease due to its pure motor presentation.

Purpose of the Study:

• To review the current understanding of immune pathogenesis in MMN.
• To discuss how immune mechanisms lead to conduction block (CB).
• To outline current treatment strategies and explore future therapeutic targets for MMN.

Main Methods:

• Review of existing literature on MMN.
• Analysis of immune pathophysiology and its relation to clinical presentation.
• Evaluation of treatment efficacy and future therapeutic avenues.

Main Results:

• GM1-specific IgM antibodies are implicated in MMN pathophysiology in about half of patients.
• Intravenous immunoglobulin (IVIg) is effective in the majority of MMN patients, as shown in multiple trials.
• Despite IVIg, progressive axonal degeneration and muscle weakness persist in some patients.

Conclusions:

• Understanding MMN's immune pathogenesis is crucial for developing targeted therapies.
• Current treatments like IVIg manage symptoms but don't halt all disease progression.
• Future research should focus on novel therapeutic targets to prevent axonal degeneration in MMN.